Literature DB >> 9139210

[Polyneuropathies in monoclonal gammopathy of undetermined significance: initial manifestation of a lymphoma].

C Drees1, M Grond, B Szelies, M Dietlein, B Salzberger, V Diehl, W D Heiss.   

Abstract

BACKGROUND: Monoclonal gammopathies-including so-called monoclonal gammopathies of undetermined significance-MGUS-may cause polyneuropathies, even if immunoglobulin concentrations are within a normal range. CASE REPORT: We report on a patient with a rapidly progressive polyneuropathy with severe motor disturbances in whom a small amount of a monoclonal IgM kappa cryoglobulin was found. Only by extensive, repeatedly performed diagnostic procedures could scattered lymphoma cells be detected. Nonspecific immunosuppression had been unsuccessful but eventually a more specific chemotherapy led to an almost complete, sustained recovery.
CONCLUSION: This case shows that in patients with a polyneuropathy of uncertain etiology monoclonal immunoglobulins should be looked for and that a MGUS can precede a lymphoma. Therefore these, patients with a MGUS and clinical deterioration despite conventional immunosuppressive treatment should undergo large-scale diagnostic check-up to make sure that the chance for an adequate chemotherapy is taken.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139210     DOI: 10.1007/bf03042293

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  11 in total

Review 1.  The spectrum of IgM monoclonal gammopathy in 430 cases.

Authors:  R A Kyle; J P Garton
Journal:  Mayo Clin Proc       Date:  1987-08       Impact factor: 7.616

Review 2.  Peripheral neuropathy associated with monoclonal IgM autoantibody.

Authors:  A J Steck; N Murray; K Dellagi; J C Brouet; M Seligmann
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

3.  'Benign' monoclonal gammopathy. A misnomer?

Authors:  R A Kyle
Journal:  JAMA       Date:  1984-04-13       Impact factor: 56.272

Review 4.  Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy.

Authors:  J M Leger; A B Younes-Chennoufi; B Chassande; G Davila; P Bouche; N Baumann; P Brunet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.

Authors:  G A Suarez; J J Kelly
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

6.  Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.

Authors:  R A Kyle
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

7.  Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component.

Authors:  L Baldini; E Nobile-Orazio; A Guffanti; S Barbieri; M Carpo; L Cro; B Cesana; I Damilano; A T Maiolo
Journal:  Am J Hematol       Date:  1994-01       Impact factor: 10.047

8.  Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies.

Authors:  M Vrethem; M Cruz; H Wen-Xin; C Malm; H Holmgren; J Ernerudh
Journal:  J Neurol Sci       Date:  1993-02       Impact factor: 3.181

9.  Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.

Authors:  N C Notermans; J H Wokke; H M Lokhorst; H Franssen; Y van der Graaf; F G Jennekens
Journal:  Brain       Date:  1994-12       Impact factor: 13.501

10.  Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia.

Authors:  I S Smith; S N Kahn; B W Lacey; R H King; R A Eames; D J Whybrew; P K Thomas
Journal:  Brain       Date:  1983-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.